Intellia Therapeutics NTLA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's operating lease ROU assets?
- Intellia Therapeutics (NTLA) reported operating lease ROU assets of $97.54M in Q1 2026.
- How has Intellia Therapeutics's operating lease ROU assets changed year-over-year?
- Intellia Therapeutics's operating lease ROU assets decreased by 29.3% year-over-year, from $137.98M to $97.54M.
- What is the long-term trend for Intellia Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Intellia Therapeutics's operating lease ROU assets has grown at a 22.1% compound annual growth rate (CAGR), from $39.11M to $105.96M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.